Client News

iOmx Therapeutics to present new data on lead programs and I/O target screening platform at AACR 2024

Abivax reports 2023 financial results and operational update

Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update

InflaRx Reports Full Year 2023 Results and Announces INF904 Development Plan

Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies

InflaRx to Announce Development Plans for INF904 and 2023 Financial Results on March 21, 2024

ActiTrexx treats first patient with novel regulatory T cell therapy against Graft-versus-Host Disease

Newron presents 2023 financial results and provides 2024 outlook

Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG

CRS initiates new chapter by appointing leading industry expert Elisabeth Lackner as Chief Executive Officer